nach oben

Erschienen in:

01.06.2013 | Article

Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes

verfasst von: M. N. Pham, H. Kolb, T. Battelino, J. Ludvigsson, P. Pozzilli, F. Zivehe, M. Roden, T. Mandrup-Poulsen, N. C. Schloot, European C-Peptide Trial

Erschienen in: Diabetologia | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Cytokines may promote or inhibit disease progression in type 1 diabetes. We investigated whether systemic proinflammatory, anti-inflammatory and regulatory cytokines associated differently with fasting and meal-stimulated beta cell function in patients with longer term type 1 diabetes.

Methods

The beta cell function of 118 patients with type 1 diabetes of duration of 0.75–4.97 years was tested using a standardised liquid mixed meal test (MMT). Serum samples obtained at −5 to 120 min were analysed by multiplex bead-based technology for proinflammatory (IL-6, TNF-α), anti-inflammatory (IL-1 receptor antagonist [IL-1RA]) and regulatory (IL-10, TGF-β_1–3) cytokines, and by standard procedures for C-peptide. Differences in beta cell function between patient groups were assessed using stepwise multiple regression analysis adjusting for sex, age, duration of diabetes, BMI, HbA_1c and fasting blood glucose.

Results

High fasting systemic concentrations of the proinflammatory cytokines IL-6 and TNF-α were associated with increased fasting and stimulated C-peptide concentrations even after adjustment for confounders (p < 0.03). Interestingly, increased concentrations of anti-inflammatory/regulatory IL-1RA, IL-10, TGF-β₁ and TGF-β₂ were associated with lower fasting and stimulated C-peptide levels (p < 0.04), losing significance on adjustment for anthropometric variables. During the MMT, circulating concentrations of IL-6 and TNF-α increased (p < 0.001) while those of IL-10 and TGF-β₁ decreased (p < 0.02) and IL-1RA and TGF-β₂ remained unchanged.

Conclusions/interpretation

The association between better preserved beta cell function in longer term type 1 diabetes and increased systemic proinflammatory cytokines and decreased anti-inflammatory and regulatory cytokines is suggestive of ongoing inflammatory disease activity that might be perpetuated by the remaining beta cells. These findings should be considered when designing immune intervention studies aimed at patients with longer term type 1 diabetes and residual beta cell function.

Nur mit Berechtigung zugänglich

Bettini M, Vignali DA (2011) T cell-driven initiation and propagation of autoimmune diabetes. Curr Opin Immunol 23:754–760PubMedCrossRef

Varanasi V, Avanesyan L, Schumann DM, Chervonsky AV (2012) Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells. Diabetes 61:2862–2870PubMedCrossRef

Rabinovitch A, Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139–1149PubMedCrossRef

Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008) Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 29:334–350PubMedCrossRef

Mandrup-Poulsen T, Pickersgill LMS, Donath MY (2010) Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol 6:158–166PubMedCrossRef

Wållberg M, Wong FS, Green EA (2011) An islet-specific pulse of TGF-β abrogates CTL function and promotes β cell survival independent of Foxp3+ T cells. J Immunol 186:2543–2551PubMedCrossRef

Tai N, Yasuda H, Xiang Y et al (2011) IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice. Clin Immunol 139:336–349PubMedCrossRef

Ardestani A, Sauter NS, Paroni F et al (2011) Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization. J Biol Chem 286:17144–17155PubMedCrossRef

Rachmiel M, Bloch O, Bistritzer T et al (2006) TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma. Cytokine 34:170–176PubMedCrossRef

10.

Christen U, von Herrath MG (2004) Manipulating the type 1 vs type 2 balance in type 1 diabetes. Immunol Res 30:309–325PubMedCrossRef

11.

Karlsson MG, Lawesson SS, Ludvigsson J (2000) Th1-like dominance in high-risk first-degree relatives of type I diabetic patients. Diabetologia 43:742–749PubMedCrossRef

12.

Pfleger C, Mortensen HB, Hansen L et al (2008) Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57:929–937PubMedCrossRef

13.

Pfleger C, Kaas A, Hansen L et al (2008) Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA_1c and disease progression in type 1 diabetes. Clin Immunol 128:57–65PubMedCrossRef

14.

Kaas A, Pfleger C, Kharagjitsingh AV et al (2012) Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed type 1 diabetes. Diabet Med 29:734–741PubMedCrossRef

15.

Han D, Leyva CA, Matheson D et al (2011) Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clin Immunol 139:290–301PubMedCrossRef

16.

Peluso I, Raguzzini A, Villano DV et al (2012) High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. Curr Pharm Des 18:85–90PubMedCrossRef

17.

Poppitt SD, Keogh GF, Lithander FE et al (2008) Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Nutrition 24:32232–32239CrossRef

18.

Nappo F, Esposito K, Cioffi M et al (2002) Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 39:1145–1150PubMedCrossRef

19.

Esposito K, Ciotola M, Sasso FC et al (2007) Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: role of tumor necrosis factor-alpha. Nutr Metab Cardiovasc Dis 17:274–279PubMedCrossRef

20.

Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971PubMedCrossRef

21.

Pham MN, Hawa MI, Pfleger C et al (2011) Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia 54:1630–1638PubMedCrossRef

22.

Highfill SL, Kelly RM, O'Shaughnessy MJ et al (2009) Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood 114:693–701PubMedCrossRef

23.

Olivieri A, De Angelis S, Dionisi S et al (2010) Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans. Clin Exp Immunol 162:407–414PubMedCrossRef

24.

Foulis AK, Farquharson MA (1986) Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus. Diabetes 35:1215–1224PubMedCrossRef

25.

Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169–2180PubMedCrossRef

26.

Jörns A, Rath KJ, Terbish T et al (2010) Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation. Endocrinology 151:3555–3565PubMedCrossRef

27.

Schloot NC, Hanifi-Moghaddam P, Goebel C et al (2002) Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice. Diabetes Metabol Res Rev 18:64–70CrossRef

28.

Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481–1489PubMedCrossRef

29.

Parsa R, Andresen P, Gillett A et al (2012) Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61:2881–2892PubMedCrossRef

30.

Subramanian L, Blumenfeld H, Tohn R et al (2012) NKT cells stimulated by long fatty acyl chain sulfatides significantly reduces the incidence of type 1 diabetes in nonobese diabetic mice. PLoS One 7:e37771PubMedCrossRef

31.

Yi Z, Diz R, Martin AJ et al (2012) Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies. Diabetes 61:2871–2880PubMedCrossRef

Titel: Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes
verfasst von: M. N. Pham
H. Kolb
T. Battelino
J. Ludvigsson
P. Pozzilli
F. Zivehe
M. Roden
T. Mandrup-Poulsen
N. C. Schloot
European C-Peptide Trial
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 6/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-013-2883-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control

Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells

Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter

Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels